Clough Capital Partners »

Denali Therapeutics shares owned by Clough Capital Partners

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Clough Capital Partners from 13F filings

Historical chart of Clough Capital Partners investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Clough Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Clough Capital Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $856k 52k 16.51

More positions owned by Clough Capital Partners

Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Boeing Company (BA)
Carnival Corp Unit 99/99/9999 (CCL)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Pulte (PHM)
D.R. Horton (DHI)
Rocket Cos Com Cl A (RKT)
Charles Schwab Corporation (SCHW)
Royal Caribbean Cruises (RCL)
Apple (AAPL)
Raytheon Technologies Corp (RTX)
Chesapeake Energy Corp (EXE)

View all positions for Clough Capital Partners

Top funds holding Denali Therapeutics

Vanguard Group
BlackRock
Baillie Gifford & Co
T. Rowe Price Investment Management
FMR
State Street Corporation
Temasek Holdings
Norges Bank Investment Management
Ubs Global Asset Management Americas
Goldman Sachs Group
Baker Bros. Advisors
Capital Research Global Investors
Alliancebernstein
Geode Capital Management
Holocene Advisors

View all funds holding Denali Therapeutics